Analysis of alpha hemoglobin stabilizing protein overexpression in murine b-thalassemia

American Journal of Hematology

Volumn 85, Issue 10, 2010, Pages 820-822

  Nasimuzzaman, Md ^a   Khandros, Eugene ^b   Wang, Xiaomei ^b   Kong, Yi ^d   Zhao, Huifen ^a   Weiss, David ^b   Rivella, Stefano ^c   Weiss, Mitchell J ^e   Persons, Derek A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d GLAXOSMITHKLINE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; ALPHA HEMOGLOBIN STABILIZING PROTEIN; HEMOGLOBIN A; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AHSP PROTEIN, HUMAN; AHSP PROTEIN, MOUSE; CHAPERONE; HEMOGLOBIN; HEMOGLOBIN ALPHA CHAIN; HYBRID PROTEIN; PLASMA PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA THALASSEMIA; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE OVEREXPRESSION; GENE TRANSFER; HEMATOLOGICAL PARAMETERS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; WILD TYPE; ANIMAL; BLOOD; DEFICIENCY; DISEASE MODEL; ERYTHROID CELL; GENE VECTOR; GENETICS; HUMAN; KNOCKOUT MOUSE; MEAN CORPUSCULAR VOLUME; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION CHIMERA; SPECIES DIFFERENCE; THERAPEUTIC USE; TRANSGENIC MOUSE;

ALPHA-GLOBINS; AMINO ACID SUBSTITUTION; ANIMALS; BETA-THALASSEMIA; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; ERYTHROCYTE INDICES; ERYTHROID CELLS; GENETIC VECTORS; HEMOGLOBINS; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR CHAPERONES; RADIATION CHIMERA; REACTIVE OXYGEN SPECIES; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY;

EID: 77957670866     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21829     Document Type: Article

References (23)

1. Weatherall DJ. Phenotype-genotype relationships in monogenic disease: Lessons from the thalassaemias. Nat Rev Genet 2001;2:245-255.
2. Bank A. Hemoglobin synthesis in beta-thalassemia: The properties of the free alpha-chains. J Clin Invest 1968;47:860-866.
3. Advani R, Rubin E, Mohandas N, Schrier SL. Oxidative red blood cell membrane injury in the pathophysiology of severe mouse beta-thalassemia. Blood 1992;79:1064-1067.
4. Sorensen S, Rubin E, Polster H, et al. The role of membrane skeletal-associated alpha-globin in the pathophysiology of beta-thalassemia. Blood 1990;75:1333-1336. (Pubitemid 20107302)
5. Gell D, Kong Y, Eaton SA, et al. Biophysical characterization of the alpha-globin binding protein alpha-hemoglobin stabilizing protein. J Biol Chem 2002;277:40602-40609.
6. Kihm AJ, Kong Y, Hong W, et al. An abundant erythroid protein that stabilizes free alpha-haemoglobin. Nature 2002;417:758-763. (Pubitemid 34640631)
7. Kong Y, Zhou S, Kihm AJ, et al. Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. J Clin Invest 2004;114:1457-1466. (Pubitemid 40385576)
8. Yu X, Kong Y, Dore LC, et al. An erythroid chaperone that facilitates folding of alpha-globin subunits for hemoglobin synthesis. J Clin Invest 2007;117:1856-1865.
9. Lai MI, Jiang J, Silver N, et al. Alpha-haemoglobin stabilising protein is a quantitative trait gene that modifies the phenotype of beta-thalassaemia. Br J Haematol 2006;133:675-682.
10. Dos Santos CO, Zhou S, Secolin R, et al. Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. Am J Hematol 2008;83:103-108.
11. Viprakasit V, Tanphaichitr VS, Chinchang W, et al. Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. Blood 2004;103:3296-3299.
12. Wang B, Fang Y, Guo X, et al. Transgenic human alpha-hemoglobin stabilizing protein could partially relieve beta(IVS-2-654)-thalassemia syndrome in model mice. Hum Gene Ther 2010;21:149-156.
13. Yang B, Kirby S, Lewis J, et al. A mouse model for beta 0-thalassemia. Proc Natl Acad Sci U S A 1995;92:11608-11612.
14. Pestina TI, Hargrove PW, Jay D, et al. Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Mol Ther 2009;17:245-252.
15. May C, Rivella S, Callegari J, et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 2000;406:82-86. (Pubitemid 30460215)
16. Hanawa H, Hargrove PW, Kepes S, et al. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia. Blood 2004;104:2281-2290.
17. Ciavatta DJ, Ryan TM, Farmer SC, Townes TM. Mouse model of human beta zero thalassemia: Targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells. Proc Natl Acad Sci U S A 1995;92:9259-9263.
18. Gell DA, Feng L, Zhou S, et al. A cis-proline in alpha-hemoglobin stabilizing protein directs the structural reorganization of alpha-hemoglobin. J Biol Chem 2009;284:29462-29469.
19. Rouyer-Fessard P, Scott MD, Leroy-Viard K, et al. Fate of alpha-hemoglobin chains and erythrocyte defects in beta-thalassemia. Ann N Y Acad Sci 1990;612:106-117.
20. Shaeffer JR, Cohen RE. Ubiquitin aldehyde increases adenosine triphosphate- dependent proteolysis of hemoglobin alpha-subunits in beta-thalassemic hemolysates. Blood 1997;90:1300-1308.
21. McClellan AJ, Tam S, Kaganovich D, Frydman J. Protein quality control: Chaperones culling corrupt conformations. Nat Cell Biol 2005;7:736-741. (Pubitemid 41079041)
22. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001;292:1552-1555.
23. Bennett EJ, Shaler TA, Woodman B, et al. Global changes to the ubiquitin system in Huntington's disease. Nature 2007;448:704-708. (Pubitemid 47236860)